Publications by authors named "Dimitri Lavillette"

Claim this Profile
A
A human antibody derived from original SARS-CoV-2 infection effectively neutralizes omicron.
Tingting Li, Bingjie Zhou, Haoyu Dong, Dimitri Lavillette, Dianfan Li

Adv Biotechnol (Singap)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2.
Shi Yu, Xu Zheng, Yanqiu Zhou, Yuhui Gao, Bingjie Zhou, Dimitri Lavillette

PLoS Pathog· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat-Denatured Lysozyme is a Novel Potential Non-alcoholic Disinfectant Against Respiratory Virus.
Suqiong Huang, Zhenghua Wu, Bingjie Zhou, Xinhui Jiang, Dimitri Lavillette

Food Environ Virol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles from Zika virus-infected cells display viral E protein that binds ZIKV-neutralizing antibodies to prevent infection enhancement.
Fanfan Zhao, Yongfen Xu, Na Liu, Dawei Lv, Yujie Chen, Dimitri Lavillette

EMBO J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy.
Lu Meng, Jialu Zha, Bingjie Zhou, Long Cao, Congli Jiang, Dimitri Lavillette

PLoS Pathog· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein.
Shiqi Xu, Yifan Wang, Yanxing Wang, Chao Zhang, Qin Hong, Dimitri Lavillette

Emerg Microbes Infect· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Dimitri Lavillette

Protein Cell· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant.
Jinkai Zang, Yannan Yin, Shiqi Xu, Weihua Qiao, Qiuyue Liu, Dimitri Lavillette

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Dimitri Lavillette

Nat Commun· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation, characterization, and structure-based engineering of a neutralizing nanobody against SARS-CoV-2.
Tingting Li, Bingjie Zhou, Yaning Li, Suqiong Huang, Zhipu Luo, Dimitri Lavillette

Int J Biol Macromol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Characterization of a Neutralizing Nanobody With Broad Activity Against SARS-CoV-2 Variants.
Tingting Li, Bingjie Zhou, Zhipu Luo, Yanling Lai, Suqiong Huang, Dimitri Lavillette

Front Microbiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
Shi Yu, Xu Zheng, Bingjie Zhou, Juan Li, Mengdan Chen, Dimitri Lavillette

Proc Natl Acad Sci U S A· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody.
Tingting Li, Hongmin Cai, Yapei Zhao, Yanfang Li, Yanling Lai, Dimitri Lavillette

EMBO Mol Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.
Bertrand Boson, Vincent Legros, Bingjie Zhou, Eglantine Siret, Cyrille Mathieu, Dimitri Lavillette

J Biol Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Dimitri Lavillette

Nat Commun· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
Yong Yang, Jinkai Zang, Shiqi Xu, Xueyang Zhang, Sule Yuan, Dimitri Lavillette

Viruses· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2.
Hebang Yao, Hongmin Cai, Tingting Li, Bingjie Zhou, Wenming Qin, Dimitri Lavillette

PLoS Pathog· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zika virus pathogenesis and current therapeutic advances.
Caroline Mwaliko, Raphael Nyaruaba, Lu Zhao, Evans Atoni, Samuel Karungu, Dimitri Lavillette

Pathog Glob Health· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation.
Jiaoyu Shan, Binbin Zhao, Zhao Shan, Jia Nie, Rong Deng, Dimitri Lavillette

PLoS Pathog· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections.
Chao Zhang, Yifan Wang, Yuanfei Zhu, Caixuan Liu, Chenjian Gu, Dimitri Lavillette

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement.
Jinkai Zang, Chenjian Gu, Bingjie Zhou, Chao Zhang, Yong Yang, Dimitri Lavillette

Cell Discov· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein.
Panke Qu, Chao Zhang, Min Li, Weimin Ma, Pei Xiong, Dimitri Lavillette

Cell Discov· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection.
Wei Zhang, Panke Qu, Dapeng Li, Chao Zhang, Qingwei Liu, Dimitri Lavillette

Antiviral Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M.
Gérald Theillet, Jérôme Martinez, Christophe Steinbrugger, Dimitri Lavillette, Bruno Coutard

Virology· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negligible contribution of M2634V substitution to ZIKV pathogenesis in AG6 mice revealed by a bacterial promoter activity reduced infectious clone.
Fanfan Zhao, Yongfen Xu, Dimitri Lavillette, Jin Zhong, Gang Zou

Sci Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis